The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content


ProMetic Life Sciences Inc closed at $3.29.

Shares have lost 3.80% over the last five days, but are unchanged over the last year to date. This security has outperformed the S&P TSX by 46.69% during the last year.

Key company metrics

  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS-$0.09
Updated May 2 4:00 PM EDT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Fiscal Quarter Endvalues in $ millions unless otherwise notedDec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015
Total other revenue--------
Total revenue14632
Gross profit9421
Total cost of revenue5111
Total operating expense28171920
Selling / general / administrative5443
Research & development18121110
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)0046
Other operating expenses, total--------
Operating income-14-12-16-18
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Income before tax-14-11-15-21
Income after tax-12-11-14-20
Income tax, total-2-1-1-1
Net income-11-9-12-19
Total adjustments to net income--------
Net income before extra. items-11-9-12-19
Minority interest2112
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-11-9-12-19
Inc. avail. to common incl. extra. items-11-9-12-19
Diluted net income-11-9-12-19
Dilution adjustment--------
Diluted weighted average shares581581569552
Diluted EPS excluding extraordinary itemsvalue per share-0.02-0.02-0.02-0.03
Dividends per sharevalue per share--
Diluted normalized EPSvalue per share-0.02-0.02-0.02-0.03